| Literature DB >> 31370775 |
Indranil Chattopadhyay1, Mukesh Verma2, Madhusmita Panda1.
Abstract
Despite advancement in cancer treatment, oral cancer has a poor prognosis and is often detected at late stage. To overcome these challenges, investigators should search for early diagnostic and prognostic biomarkers. More than 700 bacterial species reside in the oral cavity. The oral microbiome population varies by saliva and different habitats of oral cavity. Tobacco, alcohol, and betel nut, which are causative factors of oral cancer, may alter the oral microbiome composition. Both pathogenic and commensal strains of bacteria have significantly contributed to oral cancer. Numerous bacterial species in the oral cavity are involved in chronic inflammation that lead to development of oral carcinogenesis. Bacterial products and its metabolic by-products may induce permanent genetic alterations in epithelial cells of the host that drive proliferation and/or survival of epithelial cells. Porphyromonas gingivalis and Fusobacterium nucleatum induce production of inflammatory cytokines, cell proliferation, and inhibition of apoptosis, cellular invasion, and migration thorough host cell genomic alterations. Recent advancement in metagenomic technologies may be useful in identifying oral cancer-related microbiome, their genomes, virulence properties, and their interaction with host immunity. It is very important to address which bacterial species is responsible for driving oral carcinogenesis. Alteration in the oral commensal microbial communities have potential application as a diagnostic tool to predict oral squamous cell carcinoma. Clinicians should be aware that the protective properties of the resident microflora are beneficial to define treatment strategies. To develop highly precise and effective therapeutic approaches, identification of specific oral microbiomes may be required. In this review, we narrate the role of microbiome in the progression of oral cancer and its role as an early diagnostic and prognostic biomarker for oral cancer.Entities:
Keywords: biofilm; biomarker; inflammation; oral cancer; oral microbiome
Mesh:
Year: 2019 PMID: 31370775 PMCID: PMC6676258 DOI: 10.1177/1533033819867354
Source DB: PubMed Journal: Technol Cancer Res Treat ISSN: 1533-0338
Predominant Microbial Communities in Oral Cavity and Oropharyngeal Region.
| Different Sites in Oral Cavity and Oropharyngeal Region | Bacterial Species |
|---|---|
| Tongue |
|
| Oropharynx |
|
| Tooth Surface |
|
| Tonsil |
|
| Gingival crevice |
|
| Dental Plaque |
|
Alterations in Predominant Bacteria Identified in Oral Cancer.
| Name of the Bacteria | Name of the Phylum | Absolute Quantitative Status in Oral Cancer | Type of Sample | References No. |
|---|---|---|---|---|
|
| Fusobacteria | Elevated | Oral swab Saliva |
[ |
|
| Fusobacteria | Elevated | Oral swabs |
[ |
|
| Fusobacteria | Elevated | Saliva |
[ |
|
| Fusobacteria | Reduced | Saliva |
[ |
|
| Fusobacteria | Elevated | Saliva |
[ |
|
| Fusobacteria | highly abundant in HNSCC | Tissue biopsy |
[ |
|
| Actinobacteria | Reduced | Oral swab |
[ |
|
| Actinobacteria | Reduced | Tissue |
[ |
|
| Actinobacteria | Elevated | Tissue biopsy |
[ |
|
| Actinobacteria | Reduced | Tissue biopsy |
[ |
|
| Actinobacteria | Reduced | Tissue biopsy |
[ |
|
| Actinobacteria | Elevated | Saliva |
[ |
|
| Firmicutes | Reduced | Saliva |
[ |
|
| Firmicutes | Elevated | Oral rinse |
[ |
|
| Firmicutes | Elevated | Tissue biopsies and Saliva |
[ |
|
| Firmicutes | Reduced | Tissue biopsies |
[ |
|
| Firmicutes | Elevated | Oral rinse |
[ |
|
| Firmicutes | Elevated | Oral swab and Saliva |
[ |
|
| Firmicutes | Elevated | Tissue biopsy and Saliva |
[ |
|
| Firmicutes | Reduced | Oral rinse |
[ |
|
| Firmicutes | Elevated | Tissue biopsy |
[ |
|
| Firmicutes | Reduced | Saliva and tissue |
[ |
|
| Firmicutes | Elevated | Saliva and tongue tumor tissue |
[ |
|
| Firmicutes | Elevated | Oral rinse |
[ |
|
| Firmicutes | Elevated | Oral swabs |
[ |
|
| Firmicutes | highly abundant in OSCC | Oral rinse |
[ |
|
| Firmicutes | Elevated | Oral rinse |
[ |
|
| Firmicutes | Elevated | Oral rinse and saliva |
[ |
|
| Firmicutes | Elevated in laryngeal carcinoma | Oral rinse |
[ |
|
| Firmicutes | highly abundant in OSCC with stage IV | Oral rinse |
[ |
|
| Firmicutes | highly abundant in HNSCC | Tissue biopsy and saliva |
[ |
|
| Firmicutes | highly abundant in oropharyngeal cancer patients | Tissue biopsy and saliva |
[ |
|
| Firmicutes | highly abundant in oropharyngeal cancer patients | Tissue biopsy and saliva |
[ |
|
| Bacteroidetes | Elevated | Oral mouth wash |
[ |
|
| Bacteroidetes | Elevated | Tissue biopsy and saliva |
[ |
|
| Bacteroidetes | Elevated | Saliva |
[ |
|
| Bacteroidetes | Elevated | Saliva |
[ |
|
| Bacteroidetes | Reduced | Oral mouth wash |
[ |
|
| Bacteroidetes | Elevated | Oral swabs |
[ |
|
| Bacteroidetes | highly abundant in OSCC with stage IV | Oral rinse |
[ |
|
| Bacteroidetes | highly abundant | Tissue |
[ |
|
| Proteobacteria | Elevated | Saliva and swab |
[ |
|
| Proteobacteria | Elevated | Tissue biopsy |
[ |
|
| Proteobacteria | Highly abundant | Oral mouth wash |
[ |
|
| Proteobacteria | Highly abundant | Tissue |
[ |
|
| Proteobacteria | highly abundant in HNSCC | Oral rinse |
[ |
|
| Proteobacteria | highly abundant in OSCC | Oral rinse |
[ |
|
| Proteobacteria | highly abundant in OSCC with stage IV | Oral rinse |
[ |
|
| Epsilonbacteraeota | Highly abundant | Tissue |
[ |
Abbreviations: HNSCC, head and neck squamous cell carcinomas; OSCC, oral squamous cell carcinoma.
Oral Bacteria and its Association With Diagnosis and Prognosis of HNSCC.
| Bacterial Phylum/Genus/Species | Association in Diagnosis and Prognosis of Oral Cancer (Reference No.) |
|---|---|
|
| Predictive diagnostic marker for premalignant lesion and OSCC[ |
|
| Increased in higher TNM stage of HNSCC[ |
|
| Predictive diagnostic marker for HNSCC. |
|
| Inflammation in carcinogenesis induces DNA breaks in epithelial cells that drive chromosomal instability, LasI factor, secreted from |
| Abundance level of genus | Significantly reduced in low grade (T0-T2) tumor as compared to high grade tumor (T3-T4)[ |
| Abundance level of the genus | Significantly increased in low grade (T0-T2) tumor as compared to high grade tumor (T3-T4)[ |
|
| Significantly increased in the tongue tumor tissues[ |
| Level of | Significantly decreased with the progression of OSCC[ |
| Abundant level of | Progressively increased from stage 1 to stage 4 of OSCC patients; used as biomarkers for early detection and tracking for the development of OSCC. |
|
| Biomarker for stage 4 of OSCC patients. Due to high alcohol dehydrogenase (ADH) activity, |
|
| Involved in xenobiotic biodegradation and metabolism pathways that are capable to metabolize several toxicants found in cigarette smoke[ |
|
| Enriched in patients with HPV-positive cancer[ |
|
| Decreased in HPV-positive cancers[ |
|
| Possess the enzyme alcohol dehydrogenase (ADH), which metabolizes alcohol to carcinogenic acetaldehyde which induces development of oral cancer[ |
Abbreviations: HNSCC, head and neck squamous cell carcinoma; HPV, human papilloma virus; OSCC, oral squamous cell carcinoma; VSC, volatile sulfur compounds.
Figure 1.Role of Porphyromonas gingivalis in progression of oral squamous cell carcinoma (OSCC).
Figure 2.Role of Fusobacterium nucleatum in progression of oral squamous cell carcinoma (OSCC).